• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于谷胱甘肽响应性二氧化硅纳米粒子的体内靶向递送核酸和 CRISPR 基因组编辑。

In vivo targeted delivery of nucleic acids and CRISPR genome editors enabled by GSH-responsive silica nanoparticles.

机构信息

Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI 53715, USA; Wisconsin Institute for Discovery, University of Wisconsin-Madison, Madison, WI 53715, USA.

Department of Pediatrics, University of Wisconsin-Madison, Madison, WI 53706, USA; McPherson Eye Research Institute, University of Wisconsin-Madison, Madison, WI 53705, USA.

出版信息

J Control Release. 2021 Aug 10;336:296-309. doi: 10.1016/j.jconrel.2021.06.030. Epub 2021 Jun 23.

DOI:10.1016/j.jconrel.2021.06.030
PMID:34174352
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8383466/
Abstract

The rapid development of gene therapy and genome editing techniques brings up an urgent need to develop safe and efficient nanoplatforms for nucleic acids and CRISPR genome editors. Herein we report a stimulus-responsive silica nanoparticle (SNP) capable of encapsulating biomacromolecules in their active forms with a high loading content and loading efficiency as well as a well-controlled nanoparticle size (~50 nm). A disulfide crosslinker was integrated into the silica network, endowing SNP with glutathione (GSH)-responsive cargo release capability when internalized by target cells. An imidazole-containing component was incorporated into the SNP to enhance the endosomal escape capability. The SNP can deliver various cargos, including nucleic acids (e.g., DNA and mRNA) and CRISPR genome editors (e.g., Cas9/sgRNA ribonucleoprotein (RNP), and RNP with donor DNA) with excellent efficiency and biocompatibility. The SNP surface can be PEGylated and functionalized with different targeting ligands. In vivo studies showed that subretinally injected SNP conjugated with all-trans-retinoic acid (ATRA) and intravenously injected SNP conjugated with GalNAc can effectively deliver mRNA and RNP to murine retinal pigment epithelium (RPE) cells and liver cells, respectively, leading to efficient genome editing. Overall, the SNP is a promising nanoplatform for various applications including gene therapy and genome editing.

摘要

基因治疗和基因组编辑技术的快速发展提出了开发安全有效的核酸和 CRISPR 基因组编辑纳米平台的迫切需求。在此,我们报告了一种刺激响应型二氧化硅纳米颗粒(SNP),它能够以高载药含量和载药效率以及可控的纳米颗粒尺寸(约 50nm)将生物大分子封装在其活性形式中。二硫键交联剂被整合到二氧化硅网络中,当被靶细胞内化时,赋予 SNP 谷胱甘肽(GSH)响应的货物释放能力。将含咪唑的成分掺入 SNP 中,以增强内涵体逃逸能力。SNP 可以高效且具有生物相容性地递送各种货物,包括核酸(如 DNA 和 mRNA)和 CRISPR 基因组编辑物(如 Cas9/sgRNA 核糖核蛋白(RNP)和带有供体 DNA 的 RNP)。SNP 表面可以聚乙二醇化并通过不同的靶向配体进行功能化。体内研究表明,与全反式视黄酸(ATRA)缀合的视网膜下注射 SNP 和与 GalNAc 缀合的静脉内注射 SNP 可以分别有效地将 mRNA 和 RNP 递送至小鼠视网膜色素上皮(RPE)细胞和肝细胞,从而实现有效的基因组编辑。总的来说,SNP 是一种很有前途的纳米平台,可用于包括基因治疗和基因组编辑在内的各种应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5f0/8383466/f248ae17e521/nihms-1717987-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5f0/8383466/50b702f1795d/nihms-1717987-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5f0/8383466/62d04f9b83cc/nihms-1717987-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5f0/8383466/95960dfe553c/nihms-1717987-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5f0/8383466/b78e0c33ab01/nihms-1717987-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5f0/8383466/e955679e8fc9/nihms-1717987-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5f0/8383466/0d88a62e7feb/nihms-1717987-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5f0/8383466/f248ae17e521/nihms-1717987-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5f0/8383466/50b702f1795d/nihms-1717987-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5f0/8383466/62d04f9b83cc/nihms-1717987-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5f0/8383466/95960dfe553c/nihms-1717987-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5f0/8383466/b78e0c33ab01/nihms-1717987-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5f0/8383466/e955679e8fc9/nihms-1717987-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5f0/8383466/0d88a62e7feb/nihms-1717987-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5f0/8383466/f248ae17e521/nihms-1717987-f0007.jpg

相似文献

1
In vivo targeted delivery of nucleic acids and CRISPR genome editors enabled by GSH-responsive silica nanoparticles.基于谷胱甘肽响应性二氧化硅纳米粒子的体内靶向递送核酸和 CRISPR 基因组编辑。
J Control Release. 2021 Aug 10;336:296-309. doi: 10.1016/j.jconrel.2021.06.030. Epub 2021 Jun 23.
2
A pH-responsive silica-metal-organic framework hybrid nanoparticle for the delivery of hydrophilic drugs, nucleic acids, and CRISPR-Cas9 genome-editing machineries.一种 pH 响应型硅基金属有机框架杂化纳米颗粒,用于递送亲水性药物、核酸和 CRISPR-Cas9 基因组编辑系统。
J Control Release. 2020 Aug 10;324:194-203. doi: 10.1016/j.jconrel.2020.04.052. Epub 2020 May 5.
3
Comparative analysis of lipid Nanoparticle-Mediated delivery of CRISPR-Cas9 RNP versus mRNA/sgRNA for gene editing in vitro and in vivo.脂质纳米颗粒介导的 CRISPR-Cas9 RNP 与 mRNA/sgRNA 递送至体内外基因编辑的比较分析。
Eur J Pharm Biopharm. 2024 Mar;196:114207. doi: 10.1016/j.ejpb.2024.114207. Epub 2024 Feb 6.
4
Development of ionizable lipid nanoparticles and a lyophilized formulation for potent CRISPR-Cas9 delivery and genome editing.可电离脂质纳米颗粒及冻干制剂的研发,用于高效递送CRISPR-Cas9并进行基因组编辑。
Int J Pharm. 2024 Mar 5;652:123845. doi: 10.1016/j.ijpharm.2024.123845. Epub 2024 Jan 22.
5
CES1-Triggered Liver-Specific Cargo Release of CRISPR/Cas9 Elements by Cationic Triadic Copolymeric Nanoparticles Targeting Gene Editing of PCSK9 for Hyperlipidemia Amelioration.阳离子三嵌段共聚物纳米粒通过 CES1 触发肝脏特异性货物释放 CRISPR/Cas9 元件,靶向 PCSK9 基因编辑改善高血脂症
Adv Sci (Weinh). 2023 Jul;10(19):e2300502. doi: 10.1002/advs.202300502. Epub 2023 Apr 21.
6
Co-delivery of Sorafenib and CRISPR/Cas9 Based on Targeted Core-Shell Hollow Mesoporous Organosilica Nanoparticles for Synergistic HCC Therapy.基于靶向核壳结构中空介孔有机硅纳米粒子的索拉非尼和 CRISPR/Cas9 共递送用于协同 HCC 治疗。
ACS Appl Mater Interfaces. 2020 Dec 23;12(51):57362-57372. doi: 10.1021/acsami.0c17660. Epub 2020 Dec 10.
7
Guanidinium-Rich Lipopeptide-Based Nanoparticle Enables Efficient Gene Editing in Skeletal Muscles.富含胍基的脂肽纳米颗粒可实现骨骼肌内的高效基因编辑。
ACS Appl Mater Interfaces. 2023 Mar 1;15(8):10464-10476. doi: 10.1021/acsami.2c21683. Epub 2023 Feb 17.
8
Development of CRISPR/Cas Delivery Systems for In Vivo Precision Genome Editing.用于体内精准基因组编辑的CRISPR/Cas递送系统的开发
Acc Chem Res. 2023 Aug 15;56(16):2185-2196. doi: 10.1021/acs.accounts.3c00279. Epub 2023 Aug 1.
9
Engineering of monosized lipid-coated mesoporous silica nanoparticles for CRISPR delivery.用于CRISPR递送的单尺寸脂质包覆介孔二氧化硅纳米颗粒的工程设计。
Acta Biomater. 2020 Sep 15;114:358-368. doi: 10.1016/j.actbio.2020.07.027. Epub 2020 Jul 21.
10
Direct Cytosolic Delivery of CRISPR/Cas9-Ribonucleoprotein for Efficient Gene Editing.直接细胞质递送 CRISPR/Cas9 核糖核蛋白进行高效基因编辑。
ACS Nano. 2017 Mar 28;11(3):2452-2458. doi: 10.1021/acsnano.6b07600. Epub 2017 Jan 31.

引用本文的文献

1
Controlling CRISPR-Cas9 genome editing in human cells using a molecular glue degrader.使用分子胶降解剂控制人类细胞中的CRISPR-Cas9基因组编辑。
Mol Ther Nucleic Acids. 2025 Jul 21;36(3):102640. doi: 10.1016/j.omtn.2025.102640. eCollection 2025 Sep 9.
2
Precisely Targeted Nanoparticles for CRISPR-Cas9 Delivery in Clinical Applications.用于临床应用中CRISPR-Cas9递送的精准靶向纳米颗粒
Nanomaterials (Basel). 2025 Apr 2;15(7):540. doi: 10.3390/nano15070540.
3
Frontier applications of retinal nanomedicine: progress, challenges and perspectives.

本文引用的文献

1
Hierarchical Self-assembly of Discrete Metal-Organic Cages into Supramolecular Nanoparticles for Intracellular Protein Delivery.离散型金属-有机笼的分级自组装用于细胞内蛋白质递送的超分子纳米颗粒。
Angew Chem Int Ed Engl. 2021 Mar 1;60(10):5429-5435. doi: 10.1002/anie.202013904. Epub 2021 Jan 21.
2
CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy.利用靶向脂质纳米粒进行 CRISPR-Cas9 基因组编辑治疗癌症。
Sci Adv. 2020 Nov 18;6(47). doi: 10.1126/sciadv.abc9450. Print 2020 Nov.
3
Biomimetic Diselenide-Bridged Mesoporous Organosilica Nanoparticles as an X-ray-Responsive Biodegradable Carrier for Chemo-Immunotherapy.
视网膜纳米医学的前沿应用:进展、挑战与展望
J Nanobiotechnology. 2025 Feb 25;23(1):143. doi: 10.1186/s12951-025-03095-6.
4
CRISPR-Cas9 Gene Therapy: Non-Viral Delivery and Stimuli-Responsive Nanoformulations.CRISPR-Cas9基因疗法:非病毒递送与刺激响应性纳米制剂
Molecules. 2025 Jan 24;30(3):542. doi: 10.3390/molecules30030542.
5
Nonviral targeted mRNA delivery: principles, progresses, and challenges.非病毒靶向mRNA递送:原理、进展与挑战。
MedComm (2020). 2025 Jan 2;6(1):e70035. doi: 10.1002/mco2.70035. eCollection 2025 Jan.
6
Cellular functions and biomedical applications of circular RNAs.环状RNA的细胞功能与生物医学应用
Acta Biochim Biophys Sin (Shanghai). 2024 Dec 24;57(1):157-168. doi: 10.3724/abbs.2024241.
7
Magnetic Nanocarriers for pH/GSH/NIR Triple-Responsive Drug Release and Synergistic Therapy in Tumor Cells.用于肿瘤细胞中pH/谷胱甘肽/近红外三重响应药物释放及协同治疗的磁性纳米载体
ACS Omega. 2024 Dec 4;9(50):49749-49758. doi: 10.1021/acsomega.4c08267. eCollection 2024 Dec 17.
8
Non-viral gene therapy for Leber's congenital amaurosis: progress and possibilities.非病毒性基因疗法治疗莱伯先天性黑蒙:进展与前景
Nanomedicine (Lond). 2025 Feb;20(3):291-304. doi: 10.1080/17435889.2024.2443387. Epub 2024 Dec 20.
9
Development, optimization, and characterization of polymeric micelles to improve dasatinib oral bioavailability: Hep G2 cell cytotoxicity and in vivo pharmacokinetics for targeted liver cancer therapy.用于提高达沙替尼口服生物利用度的聚合物胶束的开发、优化及表征:肝癌靶向治疗的Hep G2细胞毒性和体内药代动力学
Heliyon. 2024 Oct 22;10(21):e39632. doi: 10.1016/j.heliyon.2024.e39632. eCollection 2024 Nov 15.
10
How Advanced are Nanocarriers for Effective Subretinal Injection?用于有效视网膜下注射的纳米载体有多先进?
Int J Nanomedicine. 2024 Sep 10;19:9273-9289. doi: 10.2147/IJN.S479327. eCollection 2024.
仿生二硒键桥联介孔有机硅纳米粒子作为一种 X 射线响应的可生物降解载体用于化学免疫治疗。
Adv Mater. 2020 Dec;32(50):e2004385. doi: 10.1002/adma.202004385. Epub 2020 Nov 9.
4
A Lactose-Derived CRISPR/Cas9 Delivery System for Efficient Genome Editing In Vivo to Treat Orthotopic Hepatocellular Carcinoma.一种用于体内高效基因组编辑以治疗原位肝细胞癌的乳糖衍生CRISPR/Cas9递送系统。
Adv Sci (Weinh). 2020 Jul 21;7(17):2001424. doi: 10.1002/advs.202001424. eCollection 2020 Sep.
5
Lipid-based nanoparticle technologies for liver targeting.用于肝脏靶向的基于脂质的纳米颗粒技术。
Adv Drug Deliv Rev. 2020;154-155:79-101. doi: 10.1016/j.addr.2020.06.017. Epub 2020 Jun 20.
6
Spatiotemporal Delivery of CRISPR/Cas9 Genome Editing Machinery Using Stimuli-Responsive Vehicles.利用刺激响应型载体实现 CRISPR/Cas9 基因组编辑系统的时空递呈。
Angew Chem Int Ed Engl. 2021 Apr 12;60(16):8596-8606. doi: 10.1002/anie.202005644. Epub 2020 Aug 20.
7
A pH-responsive silica-metal-organic framework hybrid nanoparticle for the delivery of hydrophilic drugs, nucleic acids, and CRISPR-Cas9 genome-editing machineries.一种 pH 响应型硅基金属有机框架杂化纳米颗粒,用于递送亲水性药物、核酸和 CRISPR-Cas9 基因组编辑系统。
J Control Release. 2020 Aug 10;324:194-203. doi: 10.1016/j.jconrel.2020.04.052. Epub 2020 May 5.
8
Hypoxia-responsive nanoparticle based drug delivery systems in cancer therapy: An up-to-date review.缺氧响应型纳米药物传递系统在癌症治疗中的应用:最新综述。
J Control Release. 2020 Mar 10;319:135-156. doi: 10.1016/j.jconrel.2019.12.041. Epub 2019 Dec 24.
9
Cell-Selective Messenger RNA Delivery and CRISPR/Cas9 Genome Editing by Modulating the Interface of Phenylboronic Acid-Derived Lipid Nanoparticles and Cellular Surface Sialic Acid.通过调节苯硼酸衍生脂质纳米颗粒与细胞表面唾液酸的界面实现细胞选择性信使 RNA 传递和 CRISPR/Cas9 基因组编辑。
ACS Appl Mater Interfaces. 2019 Dec 18;11(50):46585-46590. doi: 10.1021/acsami.9b17749. Epub 2019 Dec 9.
10
Rational designs of in vivo CRISPR-Cas delivery systems.体内 CRISPR-Cas 递送系统的合理设计。
Adv Drug Deliv Rev. 2021 Jan;168:3-29. doi: 10.1016/j.addr.2019.11.005. Epub 2019 Nov 21.